scholarly article | Q13442814 |
P50 | author | Yukinori Matsuo | Q42321855 |
Kaori Togashi | Q89794266 | ||
Yuji Nakamoto | Q91456447 | ||
P2093 | author name string | Tatsuya Higashi | |
Tsuneo Saga | |||
Masahiro Hiraoka | |||
Kenji Takayama | |||
Takashi Mizowaki | |||
Keiko Shibuya | |||
Yasushi Nagata | |||
Masaru Narabayashi | |||
Yoshiki Norihisa | |||
P433 | issue | 2 | |
P921 | main subject | adaptive radiation therapy | Q180507 |
lung cancer | Q47912 | ||
Fluorodeoxyglucose Positron Emission Tomography | Q130273243 | ||
P304 | page(s) | 200-204 | |
P577 | publication date | 2010-04-27 | |
P1433 | published in | Radiotherapy and Oncology | Q14251029 |
P1476 | title | Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer | |
P478 | volume | 97 |
Q64376629 | Circulating Tumor Cell Assessment in Presumed Early Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy: A Prospective Pilot Study |
Q36241457 | Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer |
Q35990998 | Computed tomographic features predictive of local recurrence in patients with early stage lung cancer treated with stereotactic body radiation therapy |
Q45070442 | Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings |
Q36705231 | Illustrative cases of false positive biopsies after stereotactic body radiation therapy for lung cancer based on abnormal FDG-PET-CT imaging |
Q37866792 | Imaging changes after stereotactic body radiation therapy for lung and liver tumors |
Q34762759 | Interfractional variations of tumor centroid position and tumor regression during stereotactic body radiotherapy for lung tumor |
Q64251198 | Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastases |
Q37643555 | Monitoring and management of lung cancer patients following curative-intent treatment: clinical utility of 2-deoxy-2-[fluorine-18]fluoro-d-glucose positron emission tomography/computed tomography |
Q37670432 | New techniques for assessing response after hypofractionated radiotherapy for lung cancer |
Q36327908 | Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer |
Q38849150 | Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply? |
Q51644443 | Respiratory-gated (4D) FDG-PET detects tumour and normal lung response after stereotactic radiotherapy for pulmonary metastases. |
Q36341962 | Response assessment using 18F-FDG PET early in the course of radiotherapy correlates with survival in advanced-stage non-small cell lung cancer |
Q92247615 | SUVmax Predicts Disease Progression after Stereotactic Ablative Radiotherapy in Stage I Non-small Cell Lung Cancer |
Q38161371 | Scalpel or SABR for Treatment of Early-Stage Lung Cancer: Clinical Considerations for the Multidisciplinary Team |
Q35667829 | Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies |
Q36230657 | Sublobar resection is associated with improved outcomes over radiotherapy in the management of high-risk elderly patients with Stage I non-small cell lung cancer: a systematic review and meta-analysis. |
Q55441727 | [Radiation pneumonitis after stereotactic body radiation therapy for early stage non-small cell lung cancer]. |
Search more.